Exponent (EXPO) Projected to Post Earnings on Thursday

Exponent (NASDAQ:EXPO) is expected to be posting its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Exponent to post earnings of $0.47 per share and revenue of $128.48 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, October 30th. The business services provider reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. Exponent had a net margin of 18.35% and a return on equity of 24.77%. The company had revenue of $147.12 million for the quarter, compared to the consensus estimate of $131.78 million. During the same quarter in the prior year, the firm earned $0.50 earnings per share. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Exponent Stock Down 1.6%

Shares of NASDAQ:EXPO opened at $73.49 on Thursday. The stock has a market capitalization of $3.67 billion, a PE ratio of 35.85 and a beta of 0.81. The firm’s 50 day moving average price is $72.84 and its 200-day moving average price is $70.99. Exponent has a twelve month low of $63.81 and a twelve month high of $97.57.

Exponent announced that its Board of Directors has approved a stock buyback plan on Thursday, October 30th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the business services provider to repurchase up to 3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on EXPO. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research report on Thursday, January 22nd. UBS Group reiterated a “neutral” rating and issued a $81.00 price target (up previously from $76.00) on shares of Exponent in a research note on Monday, December 15th. William Blair upgraded Exponent from a “market perform” rating to an “outperform” rating in a research report on Monday, November 17th. Finally, JPMorgan Chase & Co. started coverage on Exponent in a research report on Monday. They issued an “overweight” rating and a $100.00 target price on the stock. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.50.

Insider Activity

In other news, CEO Catherine Corrigan sold 1,663 shares of Exponent stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $72.52, for a total transaction of $120,600.76. Following the completion of the sale, the chief executive officer directly owned 92,723 shares in the company, valued at approximately $6,724,271.96. This trade represents a 1.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders sold 9,788 shares of company stock worth $693,648. 1.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Exponent

Large investors have recently bought and sold shares of the business. Quadrant Capital Group LLC purchased a new position in shares of Exponent during the 3rd quarter worth approximately $479,000. Jefferies Financial Group Inc. acquired a new position in Exponent during the third quarter worth $589,000. Osaic Holdings Inc. raised its position in Exponent by 3.8% in the second quarter. Osaic Holdings Inc. now owns 6,362 shares of the business services provider’s stock worth $476,000 after acquiring an additional 234 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in Exponent by 149.2% in the second quarter. Tower Research Capital LLC TRC now owns 5,537 shares of the business services provider’s stock valued at $414,000 after acquiring an additional 3,315 shares during the period. Finally, Scott Marsh Financial LLC purchased a new stake in shares of Exponent during the 2nd quarter worth $449,000. Institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.